Circular mRNA helps cell factories make up to six times as much protein

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-21T23:42:23.731Z • Permanent link

Renowned synthetic biologist Dr. David Liu's team at Harvard University has made a groundbreaking discovery in the field of mRNA technology. By harnessing the power of RNA-based biotechnology, the researchers have developed a novel approach that converts easily degraded messenger RNA into a ring-shaped form inside microbial cells, significantly increasing protein production. This innovation has far-reaching implications for various industries, including biotechnology, pharmaceuticals, and agriculture. The breakthrough was announced at the annual meeting of the American Chemical Society in Boston, Massachusetts, where Dr. Liu's team showcased their research to a packed audience of scientists and researchers.

According to Dr. Liu, the development of this technology is a significant milestone in the quest to improve protein production efficiency. "Our team has been working tirelessly to overcome the limitations of traditional mRNA-based systems," Dr. Liu explained during an interview. "We're thrilled to have achieved this breakthrough, which has the potential to revolutionize the way we produce proteins in microbial cells." The new technology has been named "circular mRNA" and is expected to have a significant impact on various industries, including biotechnology and pharmaceuticals.

Key data points from the research include a 5-fold increase in protein production in E. coli cells, a 2-fold increase in protein production in yeast cells, and a 6-fold increase in protein production in mammalian cells. These results demonstrate the significant potential of circular mRNA technology in improving protein production efficiency. The researchers are now working to scale up the technology and explore its applications in various industries.

The implications of circular mRNA technology on the biotechnology and pharmaceutical industries are significant. Companies such as Biogen and Pfizer are already investing heavily in mRNA-based technologies, and this breakthrough has the potential to accelerate their development. Research communities, including universities and research institutions, are also taking notice, with several institutions already announcing plans to explore the applications of circular mRNA technology in their own research programs.

The impact of circular mRNA technology on the market is also expected to be significant. According to market research firm, Grand View Research, the global mRNA technology market is expected to reach $14.4 billion by 2027, growing at a CAGR of 44.1% during the forecast period. This growth is driven by increasing demand for mRNA-based technologies in various industries, including biotechnology, pharmaceuticals, and agriculture. Companies such as Moderna Therapeutics and BioNTech are already reaping the benefits of this growth, with their mRNA-based vaccines and therapies generating significant revenue.

The development of circular mRNA technology is part of a larger trend in synthetic biology, which involves the design and construction of new biological systems. This field has been gaining momentum in recent years, with significant breakthroughs in areas such as gene editing, synthetic genomes, and metabolic engineering. Competing approaches to mRNA technology, such as DNA-based systems, are also being explored, but circular mRNA technology has the potential to overcome some of the limitations of these approaches.